Bavar­i­an Nordic se­cures BAR­DA con­tract for small­pox vac­cine

It seems that small­pox vac­ci­na­tion pro­duc­tion is weigh­ing on the mind of the US gov­ern­ment. And man­u­fac­tur­er Bavar­i­an Nordic is the lat­est com­pa­ny to ben­e­fit.

Just a few days af­ter Emer­gent, a com­pa­ny that has made gov­ern­ment con­tracts its lifeblood, ac­quired the ex­clu­sive rights to Tem­bexa from Chimerix, with a $225 mil­lion cash pay­ment and an ex­pect­ed BAR­DA con­tract, the agency has of­fered a con­tract for small­pox vac­cine pro­duc­tion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER